Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: E-cadherin, cortactin, and matrix metalloproteinase (MMP)-9 have roles in tumor development or progression, but their expression has not been fully investigated in pseudoepitheliomatous hyperplasia (PEH) and squamous cell carcinoma (SCC) of the head and neck. Methods: We evaluated the immunohistochemical expression of E-cadherin, cortactin, and MMP-9 in 29 cases of PEH and 97 cases of SCC. Additionally, we evaluated their relationship with clinicopathologic factors and prognostic implications in SCC. Results: Thirty-five cases of SCC showed reduced expression of E-cadherin, whereas none of the PEH did. A total of 20 cases and 11 cases of SCC were immunoreactive for cortactin and MMP-9, respectively, whereas none of the PEH did. In SCC, reduced expression of E-cadherin was correlated with cortactin expression and invasion depth. Cortactin expression was correlated with differentiation, T classification, and recurrence and/or metastasis. MMP-9 expression was correlated with invasion depth. Cortactin expression was correlated with poor overall survival and relapse-free survival and it was an independent prognostic factor. Conclusions: The reduced expression of E-cadherin and the expression of cortactin may be helpful for the differential diagnosis of PEH and SCC. Furthermore, cortactin expression in association with reduced E-cadherin expression is correlated with poor prognosis in SCC.
Abstract
Background: E-cadherin, cortactin, and matrix metalloproteinase (MMP)-9 have roles in tumor development or progression, but their expression has not been fully investigated in pseudoepitheliomatous hyperplasia (PEH) and squamous cell carcinoma (SCC) of the head and neck. Methods: We evaluated the immunohistochemical expression of E-cadherin, cortactin, and MMP-9 in 29 cases of PEH and 97 cases of SCC. Additionally, we evaluated their relationship with clinicopathologic factors and prognostic implications in SCC. Results: Thirty-five cases of SCC showed reduced expression of E-cadherin, whereas none of the PEH did. A total of 20 cases and 11 cases of SCC were immunoreactive for cortactin and MMP-9, respectively, whereas none of the PEH did. In SCC, reduced expression of E-cadherin was correlated with cortactin expression and invasion depth. Cortactin expression was correlated with differentiation, T classification, and recurrence and/or metastasis. MMP-9 expression was correlated with invasion depth. Cortactin expression was correlated with poor overall survival and relapse-free survival and it was an independent prognostic factor. Conclusions: The reduced expression of E-cadherin and the expression of cortactin may be helpful for the differential diagnosis of PEH and SCC. Furthermore, cortactin expression in association with reduced E-cadherin expression is correlated with poor prognosis in SCC.
참고문헌 (30)
- Sagi A, "Atypical pseudoepitheliomatous hyperplasia in squamous cell carcinoma in chronic wounds", Plast Reconstr Surg, 74, pp.315~316 (1984)
- Grandis JR, "Head and neck cancer: meeting summary and research opportunities", Cancer Res, 64, pp.8126~8129 (2004)
- Lee YS, "p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin", Cancer, 73, pp.2317~2323 (1994)
- Zarovnaya E, "Distinguishing pseudoepitheliomatous hyperplasia from squamous cell carcinoma in mucosal biopsy specimens from the head and neck", Arch Pathol Lab Med, 129, pp.1032~1036 (2005)
- Yeh KT, "The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma", Anticancer Res, 22, pp.3971~3975 (2002)
- Kyzas PA, "Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance", Am J Surg Pathol, 30, pp.185~193 (2006)
- Weed SA, "Cortactin: coupling membrane dynamics to cortical actin assembly", Oncogene, 20, pp.6418~6434 (2001)
- Helwani FM, "Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization", J Cell Biol, 164, pp.899~910 (2004)
- Clark ES, "Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia", Cancer Res, 67, pp.4227~4235 (2007)
- Hsu NY, "Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis", Dis Esophagus, 21, pp.402~408 (2008)
- Chuma M, "Overexpression of cortactinis involved in motility and metastasis of hepatocellular carcinoma", J Hepatol, 41, pp.629~636 (2004)
- Li Y, "Cortactin potentiates bone metastasis of breast cancer cells", Cancer Res, 61, pp.6906~6911 (2001)
- Li X, "Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas", Int J Oncol, 33, pp.69~79 (2008)
- Egeblad M, "New functions for the matrix metalloproteinases in cancer progression", Nat Rev Cancer, 2, pp.161~174 (2002)
- Mira E, "Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface", J Cell Sci, 117(Pt 9), pp.1847~1857 (2004)
- Ruokolainen H, "Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker", Int J Cancer, 116, pp.422~427 (2005)
- Ruokolainen H, "Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis", Clin Cancer Res, 10, pp.3110~3116 (2004)
- Barnes L, "World Health Organization classification of tumours: pathology and genetics of head and neck tumours" (2005), IARC Press
- Edge SB, "AJCC cancer staging manual. 7th ed" (2010), Springer
- Geramizadeh B, "Comparison of proliferative (Ki67) and cell adhesion (E-cadherin) markers between gastric intestinal metaplasia and Barrett’s esophagus", Indian J Gastroenterol, 28, pp.115~116 (2009)
- Yamada S, "Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma", Pathol Oncol Res, 16, pp.523~531 (2010)
- Franchi A, "Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck", Cancer, 95, pp.1902~1910 (2002)
- Impola U, "Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds", Br J Dermatol, 152, pp.720~726 (2005)
- Kurtz KA, "Decreased immunohistochemical expression of E-cadherin but not B-catenin is associated with increased risk of vascular invasion and decreased survival in head and neck squamous cell carcinomas", Lab Invest, 85(Suppl 1), pp.214~ (2005)
- Williams ME, "Chromosome 11Q13 amplification in head and neck squamous cell carcinoma", Arch Otolaryngol Head Neck Surg, 119, pp.1238~1243 (1993)
- Luo ML, "Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance", Cancer Res, 66, pp.11690~11699 (2006)
- Rodrigo JP, "EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck", Clin Cancer Res, 6, pp.3177~3182 (2000)
- Riedel F, "Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma", Int J Oncol, 17, pp.1099~1105 (2000)
- Ohashi K, "Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas", Cancer, 88, pp.2201~2209 (2000)
- Mitra RS, "Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma", Cancer Res, 68, pp.3959~3969 (2008)